4C3-12966-49232
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 278 / NC
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Registered in v-safe
-
2020-12-20
Dose 1 — Pfizer-BioNTech
- 2020-12-20
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-22
- 2020-12-29
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-21
- 2021-01-26
- 2021-02-23
-
2021-11-04
Dose 3 — Pfizer-BioNTech
- 2021-11-04
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-08
- 2021-11-10
- 2021-11-18
-
2022-05-05
Survey response — 6 months, dose 3MedDRA: Chills, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, chills, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-11-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Fever, chills, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release